CM treatment (50 ml/day, for eight weeks) of male Wistar rats with nonalcoholic fatty liver disease (NAFLD), increased GSH levels and CAT activity but decreased MDA levels (103). The gene discussed is CAT; the disease is metabolic dysfunction-associated steatotic liver disease.